| abstract |
The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions, comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4 dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the over production of melanin. |